Cytomegalovirus-specific in vitro antibody production by peripheral blood lymphocytes from renal transplant recipients with CMV infection
✍ Scribed by Michel Segondy; Laurent Barat; Georges Mourad; Marie-France Huguet; Arlette Serre; Jean-Pierre Vendrell
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 390 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cytomegalovirus‐specific in vitro antibody production (CMV‐IVAP) by peripheral blood lymphocytes (PBL) was investigated in 12 renal transplant recipients. CMV‐IVAP, CMV‐serology, and viral cultures were carried out weekly during at least 8 weeks after transplantation. Nine episodes of CMV infection occurred in eight patients. CMV‐IVAP was positive in eight episodes; IgG and/or IgA and/or IgM antibodies reacting with several CMV polypeptides were secreted by PBL. In two patients with primary CMV infection, only IgA antibodies were detected. Cytomegalovirus cultures were positive in eight episodes and serological evidence of CMV infection was obtained in five episodes. In one case, CMV‐IVAP was observed before CMV isolation and in another case, before serological evidence of CMV infection. Our study indicates that CMV‐IVAP could represent an additional tool for the diagnosis of CMV infection. Our study indicates that CMV‐IVAP could represent an additional tool for the diagnosis of CMV infection in renal transplant recipients. © 1993 Wiley‐Liss, Inc.